Mega Genomics Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	247.15	164.23	151.3	145.73	237.19
Revenue Growth (YoY)	50.49%	8.54%	3.82%	-38.56%	16.71%
Cost of Revenue	129.79	44.88	63	64	70.51
Gross Profit	117.36	119.35	88.3	81.72	166.68
Selling, General & Admin	61.65	59.46	52.83	77.79	45.95
Research & Development	17.29	19.17	22.38	-	-
Other Operating Expenses	2.16	0.52	0.35	2.48	5.87
Operating Expenses	90.79	71.23	61.58	106.13	57.98
Operating Income	26.57	48.12	26.71	-24.4	108.69
Interest Expense	-1.37	-1.72	-1.12	-0.72	-6.91
Interest & Investment Income	6.97	6.08	6.07	4.01	2.98
Currency Exchange Gain (Loss)	0.02	-0.75	1.44	11.75	-
Other Non Operating Income (Expenses)	1.03	0.1	3.51	-12.06	-8.94
EBT Excluding Unusual Items	33.21	51.83	36.61	-21.42	95.82
Gain (Loss) on Sale of Investments	0.18	1.2	-0.43	-	0.06
Other Unusual Items	-0.57	0.61	-	-	-
Pretax Income	32.83	53.63	36.18	-21.42	95.88
Income Tax Expense	5.81	8.59	6.14	-3.8	16.87
Net Income	27.02	45.05	30.04	-17.62	79.02
Net Income to Common	27.02	45.05	30.04	-17.62	79.02
Net Income Growth	-40.01%	49.96%	-	-	-0.10%
Shares Outstanding (Basic)	197	207	212	206	127
Shares Outstanding (Diluted)	197	207	212	206	127
Shares Change (YoY)	-4.81%	-2.05%	2.65%	62.09%	-
EPS (Basic)	0.14	0.22	0.14	-0.09	0.62
EPS (Diluted)	0.14	0.22	0.14	-0.09	0.62
EPS Growth	-36.98%	53.11%	-	-	-
Free Cash Flow	-	56.39	127.83	-11.92	26.47
Free Cash Flow Per Share	-	0.27	0.60	-0.06	0.21
Dividend Per Share	0.150	-	-	-	-
Gross Margin	47.48%	72.67%	58.36%	56.08%	70.27%
Operating Margin	10.75%	29.30%	17.66%	-16.75%	45.83%
Profit Margin	10.93%	27.43%	19.85%	-12.09%	33.31%
Free Cash Flow Margin	-	34.34%	84.49%	-8.18%	11.16%
EBITDA	35.69	57.24	34.97	-16.08	117.05
EBITDA Margin	14.44%	34.85%	23.11%	-11.03%	49.35%
D&A For EBITDA	9.12	9.12	8.26	8.33	8.36
EBIT	26.57	48.12	26.71	-24.4	108.69
EBIT Margin	10.75%	29.30%	17.66%	-16.75%	45.83%
Effective Tax Rate	17.69%	16.01%	16.97%	-	17.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.